Vertex News

The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... The markets moved higher yesterday, as traders apparently think China can endlessly stimulate its economy without repercussion, but the government's own news outlet, Xinhua News Agency, says there ... (more)

Complete Genomics, Inc. : Upon the news that William Blair downgraded Complete Genomics shares from Outperform to Market Perform, prices fell drastically on the day.

Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today.

However, today shares closed down over 10%. On Tuesday, the company cut success rates from the clinical trial of a new cystic-fibrosis treatment.

Facebook : Wedbush said it continues to expect Facebook to post significant long-term revenue growth despite short-term issues stemming from the NASDAQ IPO glitches, the oversupply of shares, and reports of material information being selectively disclosed to analysts.

's stock had its "overweight" rating reaffirmed by research analysts at JPMorgan Chase in a report released on Tuesday.

Vertex Corrects and Provides Additional Data from Recent Interim Analysis of Phase 2 Combination Study of VX-809 and KALYDECOa in People with Cystic Fibrosis Who Have Two Copies of the F50 CAMBRIDGE, Mass.

Vertex Pharmaceuticals announced this morning that results of a drug combination in cystic fibrosis that have caused its stock to jump 86% since May 7 were incorrect, and offered slightly different results.

's stock had its "overweight" rating restated by analysts at Barclays Capital in a research report issued to clients and investors on Friday.

May isn't in the books yet, but three health-care stocks have shot to the stratosphere.

's stock had its "overweight" rating restated by analysts at Barclays Capital in a research report issued to clients and investors on Friday.

CAMBRIDGE, Mass. -- -- Vertex Pharmaceuticals Incorporated today announced that Vertex will webcast its presentation at the Sanford C. Bernstein Strategic Decisions Conference on Wednesday, May 30, 2012 at 8:00 a.m. EDT and at the Goldman Sachs Global Healthcare Conference 2012 on Wednesday, June 6, 2012 at 1:20 p.m. PDT .

Vertex Receives European CHMP Positive Opinion for KALYDECOa , the First Medicine to Treat the Underlying Cause of Cystic Fibrosis CAMBRIDGE, Mass.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia CAMBRIDGE, Mass.-- --Vertex Pharmaceuticals Incorporated today announced that David Altshuler, M.D., Ph.D., joined its board of directors as an independent director.

Peter A. DiBiaso is the head of clinical business operations for Vertex Pharmaceuticals and responsible for the leadership of clinical business operations in support of Vertex's global development portfolio.

Josh Boger, the former chief executive of Vertex Pharmaceuticals Inc., is coming out of retirement to be executive chairman of Alkeus Pharmaceuticals, the Boston Globe reports.

The company offers INCIVEK , approved for the treatment of patients with genotype 1 hepatitis C virus infection, and KALYDECO , approved for the treatment of patients with cystic fibrosis .

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia The Crohn's and Colitis Foundation of Canada and Vertex Pharmaceuticals Announce Collaboration to Fund Research in Inflammatory Bowel Disease TORONTO & LAVAL, Quebec-- ... (more)

I can't thank you all enough for all of your support with the Raymond James Boca Grande Classic and taking time out of your busy schedules to join us for this special event May 2-5. The tournament is truly a team effort and we could not have done it without each and every one of you.

HotStockProfits.com Releases New Technical Trading Reports on Francesca's Holdings Corp , InterOil Corporation and Vertex Pharmaceuticals Incorporated Hot Stock Profits, the leading online investment portal, has just released a new technical trading report on FRAN, IOC, and VRTX .To receive these reports, please sign-up to the FREE e-newsletter at ... (more)